US Study Shows Urgent Unmet Need in Diffuse Cutaneous Scleroderma

US Study Shows Urgent Unmet Need in Diffuse Cutaneous Scleroderma

298007

US Study Shows Urgent Unmet Need in Diffuse Cutaneous Scleroderma

Despite immunosuppressive therapy, skin and lung involvement still progresses in about 20% of people with early or at-risk diffuse cutaneous systemic sclerosis (dcSSc) within the first three years, according to a study in the U.S. In addition, most people in the at-risk group went on to develop dcSSc during that period, and 6% of all patients died, with heart and gastrointestinal involvement as the main causes of death. Together, these findings highlight the urgent need…

You must be logged in to read/download the full post.